Latest Osteoporosis Stories

WASHINGTON, April 23, 2013 /PRNewswire/ -- Research has long established the anti-inflammatory benefits of tart cherries, often linked to the fruit's powerful red compounds called anthocyanins. According to new studies presented today at the prestigious Experimental Biology annual conference in Boston, MA., tart cherries could also have surprising new benefits - helping support strong bones and reducing stroke-related complications. The studies found: Reduced Risk of Bone...

Published in Techniques in Regional Anesthesia and Pain Management, Review Article Discusses Emerging VCF Treatments and Technologies SANTA CLARA, Calif., April 22, 2013 /PRNewswire/ -- In a review of minimally invasive, state-of-the-art treatments for vertebral compression fractures (VCFs), the Kiva VCF Treatment System and the Blazer Vertebral Augmentation System, both by Benvenue Medical, Inc., were highlighted among the most innovative experimental and commercial technologies...

Study offers new insights on patient and physician characteristics that contribute to osteoporosis medication adherence Nearly 30 percent of women failed to pick up their bisphosphonate prescriptions, a medication that is most commonly used to treat osteoporosis and similar bone diseases, according to a Kaiser Permanente study published this week in the journal Osteoporosis International. The failure to pick up these newly prescribed medications, called primary nonadherence, can lead to an...

Study offers new insights on patient and physician characteristics that contribute to osteoporosis medication adherence PASADENA, Calif., April 18, 2013 /PRNewswire/ -- Nearly 30 percent of women failed to pick up their bisphosphonate prescriptions, a medication that is most commonly used to treat osteoporosis and similar bone diseases, according to a Kaiser Permanente study published this week in the journal Osteoporosis International. The failure to pick up these newly prescribed...

With Nearly 57 Million Adults Age 50 and Older Affected by Osteoporosis and Low Bone Mass, NOF Announces the Break Free from Osteoporosis Campaign WASHINGTON, April 18, 2013 /PRNewswire-USNewswire/ -- The National Osteoporosis Foundation (NOF) today released new prevalence data estimating that approximately 9 million adults in the U.S. have osteoporosis and more than 48 million have low bone mass (indicated by T-scores between -1.0 and -2.5), placing them at increased risk for...

Study results suggest combination treatments may be needed to stop bone loss, fuel growth Although the drug zoledronic acid slows bone loss in osteoporosis patients, it also boosts levels of a biomarker that stops bone formation, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM). Osteoporosis weakens bones and increases the risk patients will suffer fractures. The findings suggest combination therapy...

Interventions to physicians and patients improve osteoporosis treatment at low cost Reminding primary care doctors to test at-risk patients for osteoporosis can prevent fractures and reduce health care costs, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM). Osteoporosis is a condition that is common, costly and undertreated. Low trauma fractures in older individuals are a "red flag" for...

Despite marked differences in fracture risk and services, all countries show a worrying treatment gap -- approximately 57 percent of high risk individuals are left untreated Today a panel of international experts working in cooperation with the International Osteoporosis Foundation (IOF) have published SCOPE – or Scorecard for Osteoporosis in Europe. Focusing on key aspects of service provision and uptake, the Scorecard compares how the 27 different countries within the European Union...

New report from the International Osteoporosis Foundation reveals the immense and growing burden of osteoporosis across Europe and forecasts a 25 percent increase in health economic costs by 2025 A new report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations, is the first to describe in detail the epidemiology, burden, and treatment of osteoporosis in all 27 member states of the European Union...

The Society for Women’s Health Research (SWHR) revealed today in The Journal of Women’s Health, the results of their expert, international roundtable on Menopausal Hormone Therapy (HT), illuminating the controversies and misrepresentations that have impeded women’s abilities to make choices about their own healthcare. Washington, DC (PRWEB) April 16, 2013 The Society for Women’s Health Research (SWHR) revealed today in The Journal of Women’s Health, the results of their expert,...